Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512369 · ClinicalTrials.gov registry record
Effects of PA-1 Transcriptional Regulation on Monocyte Function
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 125
- Enrollment target
NCT00512369: Clinical Trial study, sponsored by Vanderbilt University.
NCT00512369 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00512369 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Researching genetic differences in people with no prior medical conditions for better understanding of cardiac diseases through genetic research.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2006-03 |
| Est. Completion | 2011-07 |
Why NCT00512369 stopped before completion
NCT00512369 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00512369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00512369 about?
NCT00512369 is a clinical study titled "Effects of PA-1 Transcriptional Regulation on Monocyte Function". Researching genetic differences in people with no prior medical conditions for better understanding of cardiac diseases through genetic research.
What is the current status of trial NCT00512369?
This trial is currently terminated. The enrollment target is 125 participants. The study started on 2006-03. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00512369?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia